UW PACT Recruiting for Regulatory Scientist
UW Program for Advanced Cell Therapy has an open position for a Regulatory Scientist. Join a dynamic team led by Jacques Galipeau pushing forward innovative cell therapies for cancer survivors and other disorders. Interested candidates …
July 15, 2024UW Program for Advanced Cell Therapy (PACT) secures new FDA IDE to restore innate immunity post allogeneic BMT
On July 2 2024 FDA CBER approved the PACT-sponsored Investigational Device Exemption (IDE) application # 30707 named “Allogeneic, TCR αβ and CD19+ cell-depleted peripheral blood mononuclear cells”. Allogeneic BMT patients receiving post-transplant cyclophosphamide to reduce risk …
July 15, 2024PACT Completes Pilot Study of Second Dose of MSC for Dry Mouth
UW Program for Advanced Cell Therapy milestone met of sixth and last pilot study (NCT04489732) subject receiving a second administration of autologous MSC in salivary gland to treat radiation-induced dry mouth. In this pilot study, …
May 24, 2024PACT to present at ISCT Annual Meeting Next Week
UW Program for Advanced Cell Therapy sponsored pilot clinical trial update gets oral presentation at ISCT, International Society for Cell & Gene Therapy global meeting in Vancouver on May 30, 2024. The abstract “A pilot, first …
May 24, 2024From a MARSH a MSC phoenix may arise
On February 1, 2024, the UW Program for Advanced Cell Therapy sponsored MARSH phase 1 clinical trial treated its first patient at UW Carbone Cancer Center. This National Institute of Dental and Craniofacial Research (NIDCR) …
February 12, 2024- More News
Integrated personalized cell technologies for improving health outcomes in children and adults